Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda.
Twimukye A, Laker M, Odongpiny EAL, Ajok F, Onen H, Kalule I, Kajubi P, Seden K, Owarwo N, Kiragga A, Armstrong-Hough M, Katahoire A, Mujugira A, Lamorde M, Castelnuovo B.
Twimukye A, et al.
BMC Infect Dis. 2021 Nov 13;21(1):1154. doi: 10.1186/s12879-021-06851-9.
BMC Infect Dis. 2021.
PMID: 34774018
Free PMC article.